PURPOSE: Previous studies did not discriminate wild-type from hemizygous genotypes of GSTM1 and GSTT1. In this study, we investigated wild-type, hemizygous deletion, and homozygous deletion genotypes of GSTM1 and GSTT1 and lung cancer risk. METHODS: We conducted a nested case-control study of 143 primary incident lung cancer cases matched to 447 cancer-free controls. Genotyping was carried out using a real-time polymerase chain reaction (PCR)-based assay. Conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Compared to GSTM1 wild-type carriers, the relative odds of lung cancer increased from 1.49 (95% CI=0.66-3.40) to 1.80 (95% CI=0.81-4.02) for the hemizygous and homozygous deletion genotypes, respectively (p-trend=0.13). The strongest associations were seen among those who smoked less than one pack per day and had greater than or equal to one deletion variant of GSTM1 (OR=3.25; 95% CI=0.93-11.34; p-trend=0.07) whereas the reverse was observed for smokers who smoked greater than or equal to one pack per day (OR=0.80; 95% CI=0.24-2.67; p-interaction=0.08). No clear associations were observed for GSTT1 genotypes. CONCLUSIONS: Risk of lung cancer increased as the number of deletion variants increased for GSTM1, although the associations were nonsignificant. Discriminating between the wild-type, hemizygous, and homozygous deletion GSTM1 genotypes permitted a more precise characterization of the associations between GSTM1 deletion variants and lung cancer.
PURPOSE: Previous studies did not discriminate wild-type from hemizygous genotypes of GSTM1 and GSTT1. In this study, we investigated wild-type, hemizygous deletion, and homozygous deletion genotypes of GSTM1 and GSTT1 and lung cancer risk. METHODS: We conducted a nested case-control study of 143 primary incident lung cancer cases matched to 447 cancer-free controls. Genotyping was carried out using a real-time polymerase chain reaction (PCR)-based assay. Conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Compared to GSTM1 wild-type carriers, the relative odds of lung cancer increased from 1.49 (95% CI=0.66-3.40) to 1.80 (95% CI=0.81-4.02) for the hemizygous and homozygous deletion genotypes, respectively (p-trend=0.13). The strongest associations were seen among those who smoked less than one pack per day and had greater than or equal to one deletion variant of GSTM1 (OR=3.25; 95% CI=0.93-11.34; p-trend=0.07) whereas the reverse was observed for smokers who smoked greater than or equal to one pack per day (OR=0.80; 95% CI=0.24-2.67; p-interaction=0.08). No clear associations were observed for GSTT1 genotypes. CONCLUSIONS: Risk of lung cancer increased as the number of deletion variants increased for GSTM1, although the associations were nonsignificant. Discriminating between the wild-type, hemizygous, and homozygous deletion GSTM1 genotypes permitted a more precise characterization of the associations between GSTM1 deletion variants and lung cancer.
Authors: J E McWilliams; B J Sanderson; E L Harris; K E Richert-Boe; W D Henner Journal: Cancer Epidemiol Biomarkers Prev Date: 1995-09 Impact factor: 4.254
Authors: S T Saarikoski; A Voho; M Reinikainen; S Anttila; A Karjalainen; C Malaveille; H Vainio; K Husgafvel-Pursiainen; A Hirvonen Journal: Int J Cancer Date: 1998-08-12 Impact factor: 7.396
Authors: Melissa Rotunno; Tram K Lam; Aurelie Vogt; Pier Alberto Bertazzi; Jay H Lubin; Neil E Caporaso; Maria Teresa Landi Journal: Mol Carcinog Date: 2012-03-05 Impact factor: 4.784
Authors: Elena López-Knowles; Paul M Wilkerson; Ricardo Ribas; Helen Anderson; Alan Mackay; Zara Ghazoui; Aradhana Rani; Peter Osin; Ash Nerurkar; Lorna Renshaw; Alexey Larionov; William R Miller; J Michael Dixon; Jorge S Reis-Filho; Anita K Dunbier; Lesley-Ann Martin; Mitch Dowsett Journal: Breast Cancer Res Date: 2015-03-11 Impact factor: 6.466
Authors: Sandra Odebrecht Vargas Nunes; Márcia Regina Pizzo de Castro; Maria Angelica Ehara Watanabe; Roberta Losi Guembarovski; Heber Odebrecht Vargas; Edna Maria Vissoci Reiche; Helena Kaminami Morimoto; Seetal Dodd; Michael Berk Journal: Psychiatr Genet Date: 2014-06 Impact factor: 2.458
Authors: Rakhshan Ihsan; Pradeep Singh Chauhan; Ashwani Kumar Mishra; L C Singh; Jagannath Dev Sharma; Eric Zomawia; Yogesh Verma; Sujala Kapur; Sunita Saxena Journal: Indian J Med Res Date: 2014-05 Impact factor: 2.375
Authors: Hortensia Moreno-Macías; Douglas W Dockery; Joel Schwartz; Diane R Gold; Nan M Laird; Juan J Sienra-Monge; Blanca E Del Río-Navarro; Matiana Ramírez-Aguilar; Albino Barraza-Villarreal; Huiling Li; Stephanie J London; Isabelle Romieu Journal: Respir Res Date: 2013-02-04